144 related articles for article (PubMed ID: 34797032)
1. Neurofibromatosis 1 in the setting of dual diagnosis: Diagnostic and management conundrums.
Muthusamy K; El-Jabali A; Ongie LJ; Dhamija R; Babovic-Vuksanovic D
Am J Med Genet A; 2022 Mar; 188(3):911-918. PubMed ID: 34797032
[TBL] [Abstract][Full Text] [Related]
2. The NF1 microdeletion syndrome: early genetic diagnosis facilitates the management of a clinically defined disease.
Kehrer-Sawatzki H; Bäzner U; Krämer J; Lewerenz J; Pfeiffer C
J Dtsch Dermatol Ges; 2022 Mar; 20(3):273-277. PubMed ID: 35246941
[TBL] [Abstract][Full Text] [Related]
3. Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.
Kokkinou E; Roka K; Alexopoulos A; Tsina E; Nikas I; Krallis P; Thanopoulou I; Nasi L; Makrygianni E; Tsoutsou E; Kosma K; Tsipi M; Tzetis M; Frysira H; Kattamis A; Pons R
Postgrad Med; 2019 Sep; 131(7):445-452. PubMed ID: 31443616
[TBL] [Abstract][Full Text] [Related]
4. Van der Woude syndrome in twins.
Tokat C; Bilkay U; Songur E; Akin Y
J Craniofac Surg; 2005 Sep; 16(5):936-9. PubMed ID: 16192887
[TBL] [Abstract][Full Text] [Related]
5. The Diagnosis and Management of Neurofibromatosis Type 1.
Ly KI; Blakeley JO
Med Clin North Am; 2019 Nov; 103(6):1035-1054. PubMed ID: 31582003
[TBL] [Abstract][Full Text] [Related]
6. [Neurofibromatosis type 1 or Von Recklinghausen's disease].
Pinson S; Wolkenstein P
Rev Med Interne; 2005 Mar; 26(3):196-215. PubMed ID: 15777582
[TBL] [Abstract][Full Text] [Related]
7. Cleft Lip Palate in a Patient with 5q14.3 Deletion Syndrome: A Possible Unreported Feature?
Fernández Hernández L; Alcántara Ortigoza MA; Ramos Angeles SE; González-Del Angel A
Cytogenet Genome Res; 2021; 161(12):556-563. PubMed ID: 35021179
[TBL] [Abstract][Full Text] [Related]
8. Atypical Prader-Willi and 15q13.3 Microdeletion Syndromes in a Patient with an Unbalanced Translocation.
Colovati MES; Grossi BM; Nunes GD; Fock RA; Guedes DR; Melaragno MI; Cernach MCSP
Cytogenet Genome Res; 2019; 158(4):192-198. PubMed ID: 31394532
[TBL] [Abstract][Full Text] [Related]
9. A novel MEIS2 mutation explains the complex phenotype in a boy with a typical NF1 microdeletion syndrome.
Santoro C; Riccio S; Palladino F; Aliberti F; Carotenuto M; Zanobio M; Peduto C; Nigro V; Perrotta S; Piluso G
Eur J Med Genet; 2021 May; 64(5):104190. PubMed ID: 33722742
[TBL] [Abstract][Full Text] [Related]
10. Large de novo DNA deletion in a patient with sporadic neurofibromatosis 1, mental retardation, and dysmorphism.
Kayes LM; Riccardi VM; Burke W; Bennett RL; Stephens K
J Med Genet; 1992 Oct; 29(10):686-90. PubMed ID: 1359144
[TBL] [Abstract][Full Text] [Related]
11. NF1 microduplications: identification of seven nonrelated individuals provides further characterization of the phenotype.
Moles KJ; Gowans GC; Gedela S; Beversdorf D; Yu A; Seaver LH; Schultz RA; Rosenfeld JA; Torchia BS; Shaffer LG
Genet Med; 2012 May; 14(5):508-14. PubMed ID: 22241097
[TBL] [Abstract][Full Text] [Related]
12. A cytogenetic deletion, del(17)(q11.22q21.1), in a patient with sporadic neurofibromatosis type 1 (NF1) associated with dysmorphism and developmental delay.
Upadhyaya M; Roberts SH; Maynard J; Sorour E; Thompson PW; Vaughan M; Wilkie AO; Hughes HE
J Med Genet; 1996 Feb; 33(2):148-52. PubMed ID: 8929953
[TBL] [Abstract][Full Text] [Related]
13. Advances in Molecular Diagnosis of Neurofibromatosis Type 1.
Shofty B; Constantini S; Ben-Shachar S
Semin Pediatr Neurol; 2015 Dec; 22(4):234-9. PubMed ID: 26706011
[TBL] [Abstract][Full Text] [Related]
14. [Neurofibromatosis-1 microdeletion syndrome.].
Büki G; Till Á; Zsigmond A; Bene J; Hadzsiev K
Orv Hetil; 2022 Dec; 163(51):2041-2051. PubMed ID: 36528827
[TBL] [Abstract][Full Text] [Related]
15. Multiple myofibromas and an epidermal verrucous nevus in a child with neurofibromatosis type 1.
De Schepper S; Janssens S; Messiaen L; Van den Broecke C; Naeyaert JM
Dermatology; 2004; 209(3):223-7. PubMed ID: 15459537
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic difficulties and possibilities of NF1-like syndromes in childhood.
Pinti E; Nemeth K; Staub K; Lengyel A; Fekete G; Haltrich I
BMC Pediatr; 2021 Jul; 21(1):331. PubMed ID: 34325699
[TBL] [Abstract][Full Text] [Related]
17. 22q11 Deletion in children with cleft lip and palate--is routine screening justified?
Bashir MA; Hodgkinson PD; Montgomery T; Splitt M
J Plast Reconstr Aesthet Surg; 2008; 61(2):130-2. PubMed ID: 17707704
[TBL] [Abstract][Full Text] [Related]
18. [Neurofibromatosis: the most frequent hereditary tumor predisposition syndrome].
Wimmer K
Wien Med Wochenschr; 2005 Jun; 155(11-12):273-80. PubMed ID: 16035388
[TBL] [Abstract][Full Text] [Related]
19. Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1.
Corsello G; Antona V; Serra G; Zara F; Giambrone C; Lagalla L; Piccione M; Piro E
Ital J Pediatr; 2018 Apr; 44(1):45. PubMed ID: 29618358
[TBL] [Abstract][Full Text] [Related]
20. [Neurofibromatosis von Recklinghausen type 1 (NF1) - clinical picture and molecular-genetics diagnostic].
Petrák B; Bendová Š; Lisý J; Kraus J; Zatrapa T; Glombová M; Zámečník J
Cesk Patol; 2015; 51(1):34-40. PubMed ID: 25671360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
